December 14th, 11:00 AM ET
Despite exponential improvements to research technology over the last few decades, 90% of drug candidates are still failing in clinical trials. The reason for this massive translation gap is widely agreed upon, and yet rarely acknowledged: Animal models don’t sufficiently predict human response.
By continuing to rely on misleading data from animal models, R&D productivity will continue to stagnate, and critical life-saving drugs will continue to escape our grasp. It’s time to stop curing cancer in rats and start curing cancer in humans.
Organ-on-a-Chip technology is enabling researchers to decrease the translation gap by providing better insight into human response much earlier in the drug development workflow and offers the key to creating truly human-centric therapies.
In this webinar, you will learn:
- What scientists across academia and industry are saying about misleading data from conventional research models
- Why animal models fail to predict human response
- How Organ-on-a-Chip technology is helping researchers overcome pervasive barriers to bridge the translation gap